Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
breast carcinoma cell line (MCF7) and brain glioma cell line (U87) in comparison to Hoechst
LDN193189 inhibits the induction of alkaline phosphatase activity in C2C12 cells by BMP4 even when administered 12 h after BMP stimulation
whereupon it is marketed in the US as Teveten HCT and elsewhere as Teveten Plus
orally) increases urinary glucose excretion in a dose-dependent manner
Chemical Name: 3-(5-carboxylatopentyl)-2-[(1E)-3-[(2Z)-3-ethyl-2
(R)-PF-06256142 Size:Contact [email protected] for quotation breast carcinoma cell line (MCF7)(R) PF 06256142 is the R enantiomer of PF 06256142 with low active. PF 06256142 is a potent and selective orthosteric D1 receptor agonist that can reduce receptor desensitization relative to dopamine and other catechol containing agonists. Product information CAS Number: 1609583 15 4 Molecular Weight: 356. 38 Formula: C21H16N4O2 Chemical Name: 5 (4 {furo[3,2 c]pyridin 4 yloxy} 2 methylphenyl) 6 methylimidazo[1,2 a]pyrazine Smiles:
US$ 38.00
US$ 38.00
US$ 38.00
US$ 95.00
US$ 125.00
US$ 38.00
US$ 38.00
US$ 68.00
US$ 75.00
US$ 68.00
US$ 38.00
US$ 38.00